Summary
University of Southern California (USC) is a medical education and research institution that provides educational courses in the field of arts and sciences, accounting, architecture, art and design, arts and tech, business, cinematic arts, communication, journalism and dance. The institute also offers courses in dentistry, dramatic arts, engineering, gerontology, law, medicine, music, occupational therapy, pharmacy, physical therapy, professional studies, public policy and social work. It also provides undergraduate and postgraduate courses for arts, technology and international trade. It conducts research and development in the field of genomics, biomedical imaging, nanoscience, computing and digital media. USC is headquartered in Los Angeles, California, the US.
University of Southern California - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Southern California, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Southern California, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Southern California, Medical Devices Deals, 2011 to YTD 2017 9
University of Southern California, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Southern California, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 11
Emulate Enters into Research Agreement with Lawrence J. Ellison Institute for Transformative Medicine of USC 12
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 12
Ventria Bioscience Enters Into Co-Development Agreement With University of Southern California 13
University of Southern California Forms Joint Venture With University Kidney Research Organization For Kidney Research Center 14
Licensing Agreements 15
NextBio Enters Into Licensing Agreement With The University Of Southern California 15
Lotus Tissue Repair Enters Into Licensing Agreement With The University of Southern California 16
University of Southern California - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Government and Public Interest 22
Apr 04, 2017: Drugs widely used in cancer therapy increase toxicity of chemotherapy in mice 22
Dec 13, 2016: Cholesterol-fighting drugs lower risk of Alzheimer’s disease 23
Jul 08, 2016: NIH Awards USC and CHLA $36.6 Million for Clinical and Translational Science 25
Jun 06, 2016: Scientists develop protein with potential to modify brain function, memory in mice and fish 26
May 12, 2016: $200 million gift launches Lawrence J. Ellison Institute for Transformative Medicine of USC 27
Apr 11, 2016: Newly Discovered Proteins May Protect Against Aging’s Illnesses 28
Mar 30, 2016: Early use of postmenopausal hormone therapy may prevent heart disease 29
Feb 25, 2016: USC Eye Institute researchers use Human Connectome Project brain mapping techniques to unlock mysteries that can lead to vision-restoring therapies 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32List of Tables
University of Southern California, Pharmaceuticals & Healthcare, Key Facts 1
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Southern California, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Southern California, Deals By Therapy Area, 2011 to YTD 2017 8
University of Southern California, Medical Devices Deals, 2011 to YTD 2017 9
University of Southern California, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biobase Enters Into Licensing Agreement With University of Southern California And Children’s Hospital of Philadelphia 11
Emulate Enters into Research Agreement with Lawrence J. Ellison Institute for Transformative Medicine of USC 12
Caladrius Biosciences Enters into Research Agreement with University of Southern California and California Institute of Technology 12
Ventria Bioscience Enters Into Co-Development Agreement With University of Southern California 13
University of Southern California Forms Joint Venture With University Kidney Research Organization For Kidney Research Center 14
NextBio Enters Into Licensing Agreement With The University Of Southern California 15
Lotus Tissue Repair Enters Into Licensing Agreement With The University of Southern California 16
University of Southern California, Key Competitors 18
University of Southern California, Key Employees 19
University of Southern California, Subsidiaries 20List of Figures
University of Southern California, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
University of Southern California, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
University of Southern California, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Southern California, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
University of Southern California, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Southern California, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Southern California, Medical Devices Deals, 2011 to YTD 2017 9
